Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Naloxone Hydrochloride for Injection

Approval Number

国药准字H20080552

Company山西普德药业有限公司

Registration Date

August 9, 2023

Drug Information

Generic Name

注射用盐酸纳洛酮

Dosage Form

注射剂

Strength

4.0mg

Drug Type

化学药品

Registration Date

August 9, 2023

Company Information

Applicant Company

Company Name山西普德药业有限公司

Company Address

山西省大同经济技术开发区第一医药园区

Manufacturing Company

Company Name山西普德药业有限公司

Company Address

山西省大同经济技术开发区第一医药园区

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用盐酸纳洛酮 - NMPA 批准文号 | MedPath